BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 156070)

  • 1. Treatment of mycosis fungoides with topical BCNU.
    Zackheim HS; Epstein EH; Grekin DA
    Cancer Treat Rep; 1979 Apr; 63(4):623. PubMed ID: 156070
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical carmustine (BCNU) for patch/plaque mycosis fungoides.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):202-6. PubMed ID: 7986689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical chemotherapy of mycosis fungoides.
    Grekin DA; Zackheim HS; Epstein EH
    Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS; Epstein EH
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical carmustine (BCNU) in the treatment of mycosis fungoides.
    Zackheim HS
    Dermatol Ther; 2003; 16(4):299-302. PubMed ID: 14686972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
    Vonderheid EC; Dellatorre DL; Van Scott EJ
    Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical carmustine (BCNU) for mycosis fungoides and related disorders: a 10-year experience.
    Zackheim HS; Epstein EH; McNutt NS; Grekin DA; Crain WR
    J Am Acad Dermatol; 1983 Sep; 9(3):363-74. PubMed ID: 6630597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical carmustine therapy for lymphomatoid papulosis.
    Zackheim HS; Epstein EH; Crain WR
    Arch Dermatol; 1985 Nov; 121(11):1410-4. PubMed ID: 4051529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides treated with high-dose carmustine.
    Marino C; Smith C; O'Quinn JL
    Arch Dermatol; 1987 Aug; 123(8):990. PubMed ID: 3631993
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides.
    MacArthur KM; Jariwala N; Kim EJ; Rook AH
    Acta Derm Venereol; 2017 Mar; 97(3):373-374. PubMed ID: 27868149
    [No Abstract]   [Full Text] [Related]  

  • 12. Scandinavian mycosis fungoides trial.
    Thomsen K
    Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation of ultraviolet-induced carcinogenesis by 1,3-Bis(2-chloroethyl)-1-nitrosourea.
    Epstein JH
    Cancer Res; 1979 Feb; 39(2 Pt 1):408-10. PubMed ID: 761213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of 15 chemotherapeutic agents applied topically in the treatment of mycosis fungoides.
    Argyropoulos CL; Lamberg SI; Clendenning WE; Fischmann AB; Jegasothy B; Zackheim H; Peck GL
    Cancer Treat Rep; 1979 Apr; 63(4):619-21. PubMed ID: 156069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
    Heisig M; Maj J; Szepietowski JC; Reich A
    Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.
    Molin L; Thomsen K; Volden G; Aronsson A; Hammar H; Hellbe L; Wantzin GL; Roupe G
    Acta Derm Venereol; 1987; 67(3):232-6. PubMed ID: 2442936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomatoid papulosis associated with plaque-stage and granulomatous mycosis fungoides.
    Kardashian JL; Zackheim HS; Egbert BM
    Arch Dermatol; 1985 Sep; 121(9):1175-80. PubMed ID: 4037844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
    Volden G; Larsen TE
    Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.